| scholarly article | Q13442814 |
| P2093 | author name string | D J Anderson | |
| Z F Chen | |||
| H U Wang | |||
| S S Gerety | |||
| P2860 | cites work | Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 |
| neurogenin1 is essential for the determination of neuronal precursors for proximal cranial sensory ganglia | Q29615041 | ||
| Visualizing an olfactory sensory map | Q29616849 | ||
| Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate | Q29619008 | ||
| Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development | Q33633524 | ||
| In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph receptor tyrosine kinases | Q34058301 | ||
| Vasculogenesis | Q34387300 | ||
| Antiangiogenic gene therapy | Q36069788 | ||
| Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate | Q36220799 | ||
| Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2 | Q36223383 | ||
| ELF-2, a New Member of the Eph Ligand Family, Is Segmentally Expressed in Mouse Embryos in the Region of the Hindbrain and Newly Forming Somites | Q36554495 | ||
| Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease | Q39462155 | ||
| Topographically specific effects of ELF-1 on retinal axon guidance in vitro and retinal axon mapping in vivo | Q41168628 | ||
| Blood vessel formation: what is its molecular basis? | Q41288467 | ||
| Tyrosine phosphorylation of transmembrane ligands for Eph receptors | Q42802862 | ||
| Signaling Vascular Morphogenesis and Maintenance | Q45058276 | ||
| Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration. | Q45967946 | ||
| Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth | Q46218122 | ||
| Eph receptors and ephrins restrict cell intermingling and communication | Q48164807 | ||
| In vivo cell sorting in complementary segmental domains mediated by Eph receptors and ephrins | Q48195215 | ||
| The EphA4 and EphB1 receptor tyrosine kinases and ephrin-B2 ligand regulate targeted migration of branchial neural crest cells | Q52193318 | ||
| Angiogenic Therapy of the Human Heart | Q55067407 | ||
| Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning | Q24310148 | ||
| Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation | Q24316945 | ||
| Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses | Q24316974 | ||
| Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 | Q24336334 | ||
| Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk | Q24563938 | ||
| Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis | Q24608892 | ||
| PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate | Q24683266 | ||
| Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis | Q28286738 | ||
| Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis | Q28287785 | ||
| Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands | Q28294023 | ||
| Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis | Q28300359 | ||
| Nuk controls pathfinding of commissural axons in the mammalian central nervous system | Q28507318 | ||
| Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene | Q28512170 | ||
| Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 | ||
| Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | Q29547732 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | transmembrane protein | Q424204 |
| circulatory system | Q11068 | ||
| Eph receptor B4 | Q21981347 | ||
| P304 | page(s) | 403-14 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Molecular Cell | Q3319468 |
| P1476 | title | Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development | |
| P478 | volume | 4 |
| Q28510897 | A combinatorial role of angiopoietin-1 and orphan receptor TIE1 pathways in establishing vascular polarity during angiogenesis |
| Q51923232 | A genetic screen for mutations that affect cranial nerve development in the mouse. |
| Q37468040 | A genetic screen for vascular mutants in zebrafish reveals dynamic roles for Vegf/Plcg1 signaling during artery development |
| Q43240696 | A migratory role for EphrinB ligands in avian epicardial mesothelial cells. |
| Q47721941 | A novel feedback mechanism by Ephrin-B1/B2 in T-cell activation involves a concentration-dependent switch from costimulation to inhibition |
| Q40727092 | A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis |
| Q47617068 | ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis |
| Q41697025 | Abnormal arterial-venous fusions and fate specification in mouse embryos lacking blood flow |
| Q48266279 | Abnormal blood vessel development in mice lacking presenilin-1. |
| Q28277857 | All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos |
| Q45271793 | Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations |
| Q42734618 | Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy |
| Q34075013 | Angiogenesis and chronic kidney disease |
| Q29614541 | Angiogenesis in health and disease |
| Q41828383 | Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4. |
| Q30498222 | Aplexone targets the HMG-CoA reductase pathway and differentially regulates arteriovenous angiogenesis |
| Q35903876 | Arterialization and anomalous vein wall remodeling in varicose veins is associated with upregulated FoxC2-Dll4 pathway |
| Q34810312 | Arteries and veins: making a difference with zebrafish |
| Q28513355 | Arteriovenous malformations in mice lacking activin receptor-like kinase-1 |
| Q28506090 | Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis |
| Q30414333 | Attenuation of ephrinB2 reverse signaling decreases vascularized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy |
| Q36510991 | Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice |
| Q37746510 | Axon guidance molecules in vascular patterning |
| Q36648644 | BRG1 promotesCOUP-TFIIexpression and venous specification during embryonic vascular development |
| Q35937580 | Blood vessel patterning at the embryonic midline |
| Q36402724 | Bone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases |
| Q26765120 | Building and re-building the heart by cardiomyocyte proliferation |
| Q36672272 | Cardiovascular genomics: a current overview of in vivo and in vitro studies |
| Q27325791 | Cartilage-specific deletion of ephrin-B2 in mice results in early developmental defects and an osteoarthritis-like phenotype during aging in vivo |
| Q38703370 | Cell type-specific localization of Ephs pairing with ephrin-B2 in the rat postnatal pituitary gland |
| Q36801092 | Cell-cell signaling in the neurovascular unit |
| Q48745802 | Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis |
| Q28214281 | Characterization of the Epha1 receptor tyrosine kinase: expression in epithelial tissues |
| Q39256747 | Clinical implications of EphB4 receptor expression in pancreatic cancer |
| Q36396980 | Coexistence of EphB1 and EphrinB2 in Port Wine Stain Endothelial Progenitor Cells Contributes to Clinicopathological Vasculature Dilatation. |
| Q48030369 | Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers |
| Q36484515 | Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers |
| Q33752236 | Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis |
| Q35952161 | Common cues in vascular and axon guidance |
| Q34433723 | Common mechanisms of nerve and blood vessel wiring |
| Q24290904 | Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5 |
| Q104510621 | Comprehensive phenotyping of endothelial cells using flow cytometry 1: Murine |
| Q35181668 | Contact-dependent signaling during the late events of platelet activation. |
| Q39370974 | Control of blood vessel identity: from embryo to adult. |
| Q33941577 | Control of cell behaviour by signalling through Eph receptors and ephrins. |
| Q34104147 | Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma |
| Q91762067 | Core Element Cloning, Cis-Element Mapping and Serum Regulation of the Human EphB4 Promoter: A Novel TATA-Less Inr/MTE/DPE-Like Regulated Gene |
| Q30537567 | Coronary veins determine the pattern of sympathetic innervation in the developing heart |
| Q54543769 | Critical role of the axonal guidance cue EphrinB2 in lung growth, angiogenesis, and repair. |
| Q36844220 | Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors |
| Q41579824 | Deficiency of TLR4 homologue RP105 aggravates outward remodeling in a murine model of arteriovenous fistula failure. |
| Q30592602 | Deletion of Rbpj from postnatal endothelium leads to abnormal arteriovenous shunting in mice. |
| Q38144750 | Development and pathologies of the arterial wall |
| Q52113809 | Developmental expression of EphB6 in the thymus: lessons from EphB6 knockout mice |
| Q36489774 | Differentiation of arterial and venous endothelial cells and vascular morphogenesis |
| Q30855572 | Dissecting BMP signaling input into the gene regulatory networks driving specification of the blood stem cell lineage |
| Q37850141 | Dissection of Cardiovascular Development and Disease Pathways in Zebrafish |
| Q30581940 | Distinct Notch signaling outputs pattern the developing arterial system. |
| Q34872708 | Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis |
| Q28506356 | Dosage-dependent requirement for mouse Vezf1 in vascular system development |
| Q31813080 | Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction |
| Q91893672 | Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients |
| Q48089344 | EPHB4 Mutation Implicated in Capillary Malformation-Arteriovenous Malformation Syndrome: A Case Report |
| Q34129223 | EPHB4 gene polymorphisms and risk of intracranial hemorrhage in patients with brain arteriovenous malformations |
| Q38951519 | EPHB4 tyrosine-kinase receptor expression and biological significance in soft tissue sarcoma |
| Q44636591 | Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors |
| Q41061677 | Embryonic Stem Cell Differentiation to Functional Arterial Endothelial Cells through Sequential Activation of ETV2 and NOTCH1 Signaling by HIF1α. |
| Q37046062 | Embryonic cardiac chamber maturation: Trabeculation, conduction, and cardiomyocyte proliferation |
| Q83226379 | Endothelial EphB4 maintains vascular integrity and transport function in adult heart |
| Q36342350 | Endothelial cells and VEGF in vascular development |
| Q39699715 | Endothelial cells regulate cardiomyocyte development from embryonic stem cells |
| Q38085095 | Endothelial heterogeneity and adhesion molecules N-glycosylation: implications in leukocyte trafficking in inflammation. |
| Q44138748 | Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. |
| Q85010601 | Eph family receptors as therapeutic targets |
| Q29619988 | Eph receptor signalling casts a wide net on cell behaviour |
| Q34103639 | Eph receptors and ephrin ligands: embryogenesis to tumorigenesis |
| Q38080387 | Eph receptors and their ligands: Promising molecular biomarkers and therapeutic targets in prostate cancer |
| Q28677705 | Eph signaling: a structural view |
| Q38209232 | Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics |
| Q53193478 | Eph-B4 mediates vein graft adaptation by regulation of endothelial nitric oxide synthase. |
| Q34681404 | Eph-B4 prevents venous adaptive remodeling in the adult arterial environment |
| Q37971902 | Eph-dependent cell-cell adhesion and segregation in development and cancer. |
| Q24611588 | Eph/ephrin molecules--a hub for signaling and endocytosis |
| Q38436466 | Eph/ephrin signaling in the kidney and lower urinary tract |
| Q37120500 | Eph/ephrin signaling maintains the boundary of dorsal forerunner cell cluster during morphogenesis of the zebrafish embryonic left-right organizer |
| Q37951183 | Eph/ephrin signaling: genetic, phosphoproteomic, and transcriptomic approaches. |
| Q38267753 | EphA3 biology and cancer. |
| Q48486658 | EphA4 regulates central nervous system vascular formation |
| Q30479634 | EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling |
| Q35894825 | EphB3 marks delaminating endocrine progenitor cells in the developing pancreas |
| Q34747922 | EphB4 as a therapeutic target in mesothelioma |
| Q40327178 | EphB4 controls blood vascular morphogenesis during postnatal angiogenesis |
| Q34769816 | EphB4 expression in pterygium is associated with microvessel density |
| Q35486972 | EphB4 forward signalling regulates lymphatic valve development |
| Q35676082 | EphB4 forward-signaling regulates cardiac progenitor development in mouse ES cells |
| Q39354035 | EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer target |
| Q40365399 | EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. |
| Q44390853 | EphB4 receptor tyrosine kinase transgenic mice develop glomerulopathies reminiscent of aglomerular vascular shunts |
| Q38972704 | EphB4 regulates the growth and migration of pancreatic cancer cells |
| Q37466344 | EphB4-targeted imaging with antibody h131, h131-F(ab')2 and h131-Fab |
| Q49709391 | EphB4: A promising target for upper aerodigestive malignancies |
| Q42174452 | Epha3 acts as proangiogenic factor in multiple myeloma |
| Q33613966 | Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1. |
| Q36962774 | Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment |
| Q37658786 | Ephrin expression and function in cancer. |
| Q39356254 | Ephrin ligands and Eph receptors contribution to hematopoiesis |
| Q35536905 | Ephrin type-B receptor 4 activation reduces neointimal hyperplasia in human saphenous vein in vitro. |
| Q34536346 | Ephrin-As as receptors in topographic projections |
| Q28212190 | Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction |
| Q39248946 | Ephrin-B stimulation of calvarial bone formation. |
| Q47659849 | Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. |
| Q34022315 | Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis |
| Q30493939 | Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding. |
| Q44956263 | Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development |
| Q38404246 | EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown |
| Q37317736 | EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. |
| Q21145780 | EphrinB/EphB signaling controls embryonic germ layer separation by contact-induced cell detachment |
| Q36719255 | EphrinB2 Reverse Signaling Protects against Capillary Rarefaction and Fibrosis after Kidney Injury |
| Q57265483 | EphrinB2 Signalling in Osteoblast Differentiation, Bone Formation and Endochondral Ossification |
| Q52602937 | EphrinB2 activation enhances angiogenesis, reduces amyloid-β deposits and secondary damage in thalamus at the early stage after cortical infarction in hypertensive rats |
| Q35227778 | EphrinB2 controls vessel pruning through STAT1-JNK3 signalling |
| Q36959852 | EphrinB2 regulates the emergence of a hemogenic endothelium from the aorta |
| Q99211437 | EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity |
| Q92020719 | EphrinB2-EphB4-RASA1 Signaling in Human Cerebrovascular Development and Disease |
| Q38842539 | EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease. |
| Q34701751 | Ephs and ephrins close ranks |
| Q44569763 | Ephs and ephrins during early stages of chick embryogenesis |
| Q28586276 | Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis |
| Q34031959 | Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis |
| Q33264945 | Expression of ephrin in retinal neovascularization and iris rubeosis |
| Q42444483 | Fluid shear stress induces arterial differentiation of endothelial progenitor cells |
| Q36103385 | Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice |
| Q64054528 | Functional characterization of iPSC-derived arterial- and venous-like endothelial cells |
| Q84514621 | Generation of transgenic mice overexpressing EfnB2 in endothelial cells |
| Q36379514 | Genetic and epigenetic mechanisms in the early development of the vascular system |
| Q37467785 | Gradients of Eph-A6 expression in primate retina suggest roles in both vascular and axon guidance |
| Q35568152 | Growing and shaping the vascular tree: multiple roles for VEGF |
| Q57072959 | Guidance Molecules in Vascular Smooth Muscle |
| Q50696862 | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia |
| Q37594746 | Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. |
| Q28505269 | Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants |
| Q39004714 | Heart Development, Angiogenesis, and Blood-Brain Barrier Function Is Modulated by Adhesion GPCRs |
| Q30482359 | Hedgehog signaling is critical for maintenance of the adult coronary vasculature in mice |
| Q43119202 | Hedgehog signaling to distinct cell types differentially regulates coronary artery and vein development |
| Q54593908 | High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability. |
| Q33511250 | Human placental-specific epipolymorphism and its association with adverse pregnancy outcomes |
| Q64270938 | Hypoxia promotes differentiation of adipose-derived stem cells into endothelial cells through demethylation of ephrinB2 |
| Q54338851 | Increased EphB2 expression predicts cholangiocarcinoma metastasis |
| Q92321643 | Increased autophagy in EphrinB2-deficient osteocytes is associated with elevated secondary mineralization and brittle bone |
| Q35828791 | Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion |
| Q90123314 | Inhibition of erythropoietin-producing hepatoma receptor B4 (EphB4) signaling suppresses the vascularization and growth of endometriotic lesions |
| Q27664544 | Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors |
| Q24534800 | Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred |
| Q37994636 | Intercellular cross-talk among bone cells: new factors and pathways. |
| Q47105284 | Intraluminal valves: development, function and disease. |
| Q33651585 | Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in mice |
| Q34428794 | Isolation of arterial-specific genes by subtractive hybridization reveals molecular heterogeneity among arterial endothelial cells |
| Q46862943 | KLF2 transcription factor modulates blood vessel maturation through smooth muscle cell migration |
| Q38765961 | KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors |
| Q31965129 | Kinase-dependent and kinase-independent functions of EphA4 receptors in major axon tract formation in vivo. |
| Q37971729 | Life is a pattern: vascular assembly within the embryo |
| Q24301313 | Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway |
| Q28506951 | Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor |
| Q35743851 | Manipulating angiogenesis in medicine |
| Q28208291 | Mechanisms and functions of Eph and ephrin signalling |
| Q35962939 | Mechanisms and regulation of lung vascular development |
| Q38704281 | Mechanisms of ephrin-Eph signalling in development, physiology and disease. |
| Q37509308 | Microvascular pericytes in healthy and diseased kidneys |
| Q84736698 | Molecular Mechanisms of Tumor Angiogenesis |
| Q35551132 | Molecular basis of angiogenesis and cancer |
| Q35066914 | Molecular control of arterial-venous blood vessel identity |
| Q37593631 | Molecular identification of venous progenitors in the dorsal aorta reveals an aortic origin for the cardinal vein in mammals |
| Q36766808 | Molecular mechanisms of pulmonary vascular development |
| Q35564001 | Motor axon migration: a long way to go |
| Q28304868 | Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system |
| Q28205325 | Multiple roles of EPH receptors and ephrins in neural development |
| Q41337528 | Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: implications for xenograft models of human prostate cancer. |
| Q34014661 | Myocardium-derived angiopoietin-1 is essential for coronary vein formation in the developing heart |
| Q38087875 | Navigation rules for vessels and neurons: cooperative signaling between VEGF and neural guidance cues |
| Q36264747 | Neural crest defects in ephrin-B2 mutant mice are non-autonomous and originate from defects in the vasculature |
| Q38085110 | New Insights into the Developmental Mechanisms of Coronary Vessels and Epicardium |
| Q54624593 | New vandetanib analogs: fused tricyclic quinazolines with antiangiogenic potential. |
| Q35252574 | Notch expression patterns in the retina: An eye on receptor-ligand distribution during angiogenesis |
| Q29620377 | Notch signaling is essential for vascular morphogenesis in mice |
| Q24299001 | Notch signaling is essential for ventricular chamber development |
| Q30493962 | Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants |
| Q35591804 | Notch1 is pan-endothelial at the onset of flow and regulated by flow. |
| Q41761841 | Notch4 normalization reduces blood vessel size in arteriovenous malformations |
| Q33745300 | Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth |
| Q37681157 | Novel aspects of corneal angiogenic and lymphangiogenic privilege. |
| Q28479031 | Novel strategy for selection of monoclonal antibodies against highly conserved antigens: phage library panning against ephrin-B2 displayed on yeast |
| Q36108192 | Numb family proteins: novel players in cardiac morphogenesis and cardiac progenitor cell differentiation |
| Q37657570 | Of plasticity and specificity: dialectics of the micro- and macro-environment and the organ phenotype |
| Q34032032 | Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). |
| Q45232514 | Overexpression of EphB4, EphrinB2, and epidermal growth factor receptor in papillary thyroid carcinoma: A pilot study |
| Q49804818 | Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments. |
| Q28506962 | Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos |
| Q28585965 | PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature |
| Q35785713 | PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells |
| Q35018094 | Plumbing the mysteries of vascular development using the zebrafish |
| Q37345639 | Possible novel targets for therapeutic angiogenesis |
| Q35750148 | Proangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesis |
| Q64111876 | Prostaglandin E2 promotes embryonic vascular development and maturation in zebrafish |
| Q33872553 | RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity |
| Q92656933 | RASA1-dependent cellular export of collagen IV controls blood and lymphatic vascular development |
| Q34230386 | Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion |
| Q35825299 | Recent advances in biomarkers and potential targeted therapies in head and neck squamous cell carcinoma |
| Q24798176 | Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer |
| Q35221906 | Receptor tyrosine kinase EphB4 is a survival factor in breast cancer |
| Q36763861 | Reduced adult endothelial cell EphB4 function promotes venous remodeling. |
| Q34382591 | Reducing Jagged 1 and 2 levels prevents cerebral arteriovenous malformations in matrix Gla protein deficiency |
| Q38012210 | Regulation of VEGF signaling by membrane traffic |
| Q38284407 | Regulation of signaling interactions and receptor endocytosis in growing blood vessels |
| Q36765650 | Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases. |
| Q38386097 | Renal endothelial injury and microvascular dysfunction in acute kidney injury |
| Q36680080 | Ribozyme technology for cancer gene target identification and validation |
| Q46465346 | Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity. |
| Q54238065 | Role of EFNB2/EPHB4 signaling in spiral artery development during pregnancy: An appraisal |
| Q89052192 | Role of Endothelial-to-Mesenchymal Transition in the Pathogenesis of Central Nervous System Hemangioblastomas |
| Q26860972 | Role of Eph/ephrin tyrosine kinase in malignant glioma |
| Q38201075 | Role of ROBO4 signalling in developmental and pathological angiogenesis |
| Q44589906 | Role of ephrin B2 in human retinal endothelial cell proliferation and migration |
| Q51966746 | SRG3, a core component of mouse SWI/SNF complex, is essential for extra-embryonic vascular development. |
| Q35025018 | Sema3D and Sema7A have distinct expression patterns in chick embryonic development |
| Q35583161 | Sema3D, Sema3F, and Sema5A are expressed in overlapping and distinct patterns in chick embryonic heart |
| Q46623662 | Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin |
| Q37898063 | Signal transduction in vasculogenesis and developmental angiogenesis |
| Q28210262 | Signals from Eph and ephrin proteins: a developmental tool kit |
| Q28204868 | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature |
| Q36976443 | Similarities between angiogenesis and neural development: what small animal models can tell us. |
| Q36784413 | Single-Cell Lineage Tracing Reveals that Oriented Cell Division Contributes to Trabecular Morphogenesis and Regional Specification |
| Q44172489 | Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. |
| Q37185221 | Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells |
| Q38416404 | Spatiotemporal mapping of vascularization and innervation in the fetal murine intestine. |
| Q30896811 | Specialization of tumour vasculature |
| Q33973350 | Specification of arterial, venous, and lymphatic endothelial cells during embryonic development |
| Q35925849 | Structures of axon guidance molecules and their neuronal receptors |
| Q37141121 | Subepicardial endothelial cells invade the embryonic ventricle wall to form coronary arteries |
| Q28509237 | Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity |
| Q36518309 | Targeting the EphB4 Receptor for Cancer Diagnosis and Therapy Monitoring |
| Q52692067 | The Blood-Brain Barrier and the EphR/Ephrin System: Perspectives on a Link Between Neurovascular and Neuropsychiatric Disorders |
| Q38006838 | The Eph/Ephrin family in cancer metastasis: communication at the service of invasion |
| Q35832019 | The aortic ring model of angiogenesis: a quarter century of search and discovery |
| Q38090418 | The cell-matrix interface: a possible target for treating retinal vascular related pathologies |
| Q37947082 | The cytochrome P450 pathway in angiogenesis and endothelial cell biology. |
| Q31859070 | The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration. |
| Q34078717 | The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder |
| Q46699319 | The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization |
| Q28212424 | The ephrins and Eph receptors in angiogenesis |
| Q26770162 | The force within: endocardial development, mechanotransduction and signalling during cardiac morphogenesis |
| Q38215321 | The functional diversity of essential genes required for mammalian cardiac development. |
| Q35299351 | The impact of anti-angiogenic agents on cancer therapy |
| Q37946049 | The initiation of blood flow and flow induced events in early vascular development |
| Q33336877 | The molecular phylogeny of eph receptors and ephrin ligands |
| Q28088632 | The molecular regulation of arteriovenous specification and maintenance |
| Q38031457 | The murine allantois: a model system for the study of blood vessel formation |
| Q44216042 | The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system |
| Q36052725 | The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems. |
| Q50079573 | The product of the γ-secretase processing of ephrinB2 regulates VE-cadherin complexes and angiogenesis |
| Q36610209 | The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome |
| Q38609464 | The role of Eph/ephrin molecules in stromal–hematopoietic interactions |
| Q37039134 | The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade |
| Q33677805 | The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis |
| Q35849505 | The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth |
| Q38174793 | Therapeutic targeting of EPH receptors and their ligands |
| Q92185709 | Tie2 regulates endocardial sprouting and myocardial trabeculation |
| Q37304957 | Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model |
| Q37097453 | Tissue-specific venous expression of the EPH family receptor EphB1 in the skin vasculature. |
| Q37188074 | Transgenic mouse models of angiogenesis and lymphangiogenesis |
| Q28593395 | Transient expression of ephrin b2 in perinatal skin is required for maintenance of keratinocyte homeostasis |
| Q43559492 | Tumor necrosis factor-alpha induction of endothelial ephrin A1 expression is mediated by a p38 MAPK- and SAPK/JNK-dependent but nuclear factor-kappa B-independent mechanism. |
| Q84543407 | VEGF and ephrin-B2: a bloody duo |
| Q38047482 | Vascular contributions to early ovarian development: potential roles of VEGFA isoforms |
| Q38246267 | Vascular development and hemodynamic force in the mouse yolk sac. |
| Q52165379 | Vascular developmental biology: getting nervous |
| Q35855622 | Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis |
| Q36867965 | Vascular endothelial growth factor-A inhibits EphB4 and stimulates delta-like ligand 4 expression in adult endothelial cells. |
| Q29614780 | Vascular-specific growth factors and blood vessel formation |
| Q64931798 | Vasculogenesis drives pulmonary vascular growth in the developing chick embryo |
| Q61443332 | Venous identity requires BMP signalling through ALK3 |
| Q34087706 | Vessel Arterial-Venous Plasticity in Adult Neovascularization |
| Q34119813 | Whole-Mount Confocal Microscopy for Vascular Branching Morphogenesis |
| Q35392161 | Whole-mount immunohistochemical analysis for embryonic limb skin vasculature: a model system to study vascular branching morphogenesis in embryo. |
| Q35937586 | Wiring the vascular circuitry: from growth factors to guidance cues |
| Q34784659 | Won't you be my neighbor? Local induction of arteriogenesis. |
| Q48099876 | Zebrafish Tmem230a cooperates with the Delta/Notch signaling pathway to modulate endothelial cell number in angiogenic vessels. |
| Q33667001 | c-Abl tyrosine kinase regulates cardiac growth and development |
| Q47074043 | sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation |
Search more.